Jesús García-Donas Jiménez-rekin lankidetzan egindako argitalpenak (7)

2024

  1. Proteomic profiles of peritoneal fluid-derived small extracellular vesicles correlate with patient outcome in ovarian cancer

    The Journal of clinical investigation, Vol. 134, Núm. 10

2023

  1. Randomized phase II clinical trial of ruxolitinib plus simvastatin in COVID19 clinical outcome and cytokine evolution

    Frontiers in Immunology, Vol. 14

2022

  1. MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma

    Virchows Archiv, Vol. 480, Núm. 4, pp. 855-871

  2. MEK inhibitor sensitivity in BRAF fusion-driven prostate cancer

    Clinical and Translational Oncology, Vol. 24, Núm. 12, pp. 2432-2440

  3. Multivariate feature selection and autoencoder embeddings of ovarian cancer clinical and genetic data

    Expert Systems with Applications, Vol. 206

2021

  1. A Resampling Univariate Analysis Approach to Ovarian Cancer from Clinical and Genetic Data

    IEEE Access, Vol. 9, pp. 25959-25972

  2. Text Analytics and Mixed Feature Extraction in Ovarian Cancer Clinical and Genetic Data

    IEEE Access, Vol. 9, pp. 58034-58051